Features
Is There a Role for SLT After MIGS?
A practical framework for patient selection and clinical decision-making when intraocular pressure rises after minimally invasive glaucoma surgery.
By Shivani S. Kamat, MD
Predicting Success After Angle Surgery
Clinical clues, imaging biomarkers, and genetics may help identify the patients most likely to benefit from angle-based MIGS.
By Si Jia Chen, BS, Arsham Sheybani, MD
Procedural Pharmaceutical Lessons From Early Adopters
Experienced glaucoma surgeons share practical pearls on integrating sustained drug delivery into practice.
By Christine Funke, MD, J. Morgan Micheletti, MD, FACS, Jason Bacharach, MD, et al.
Perspectives on Medicare’s Proposed iDose TR Coverage Policy
Six glaucoma specialists discuss Medicare's proposed local coverage determinations (LCDs) for iDose TR and how they could affect patient care.
By Steven R. Sarkisian, Jr., MD, Inder Paul Singh, MD, Savak “Sev” Teymoorian, MD, MBA, et al.
Beyond Today’s Implants: The Next Generation of Sustained Drug Delivery
The investigational pipeline is moving to address challenging questions of treatment duration, repeatability, and clinical integration.
By Ciera D. Johnson, BS, Rachel Chapman, Samantha Goldburg, MD, et al.
Getting the Details Right in Glaucoma Surgery
Craig J. Chaya, MD, discusses meticulous mitomycin C application and why small technical decisions can influence surgical outcomes.
By Mary Qiu, MD,, Craig J. Chaya, MD
Three Suturing Pearls for Glaucoma Surgery
Erin A. Boese, MD, discusses techniques for controlling flow through nonvalved drainage devices, managing suture tails, and optimizing conjunctival closure.
By Shivani S. Kamat, MD
Life Biosciences Reports First ER-100 Clinical Data
Sharon Rosenzweig-Lipson, PhD, discusses preliminary safety and visual field findings from the first 3 participants in a trial of epigenetic restoration therapy for optic neuropathies.
By Sharon Rosenzweig-Lipson, PhD
Glaucoma Neuroprotection: Still Searching for the Right Notes
Derek S. Welsbie, MD, reviewed the potential of nicotinamide and GLP-1 receptor agonists to protect the optic nerve, along with the limitations of current evidence, during Glaucoma Subspecialty Day at AAO 2026 in New Orleans.
By Jim Gallagher, senior managing editor
Getting Back to Basics in Angle Surgery
Elena Bitrian, MD, shares practical tips for angle visualization, precise instrument handling, and troubleshooting challenging cases.
By Mary Qiu, MD,, Elena Bitrian, MD
Web Exclusives
Revisiting Strategies for Glaucoma Education
Improve patient adherence and outcomes with these simple tips.
By Inder Paul Singh, MD
Departments
The Prevention Paradox
From the Editor
Glaucoma treatment asks patients, physicians, and payers to act before the consequences are visible.
By Nathan Radcliffe, MD
Letter to Editor and Response
Concern Regarding Coding Guidance and Relevant Financial Disclosures
By Sean Ianchulev, MD, MPH, Kevin J. Corcoran, COE, FNAO
Glaucoma Trials Tracker
Access Glaucoma Physician's listing of all active interventional clinical trials related to glaucoma.